StonvexLoading…
StonvexStonvexStonvexCore line items from NXST's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $4.95B | $5.41B | $4.93B | $5.21B |
Operating Income | $849.00M | $1.27B | $708.00M | $1.31B |
Net Income | $109.00M | $722.00M | $346.00M | $971.00M |
EPS (Diluted) | $3.00 | $21.41 | $9.64 | $24.16 |
Total Assets | $10.85B | $11.47B | $12.08B | $12.68B |
Total Liabilities | $8.78B | $9.20B | $9.77B | $9.91B |
Cash & Equivalents | $280.00M | $144.00M | $135.00M | $204.00M |
Free Cash Flow OCF − CapEx | $743.00M | $1.10B | $850.00M | $1.25B |
Shares Outstanding | 30.33M | 30.62M | 35.83M | 40.19M |